Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells.
about
Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer.Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cellsCategorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patientsA Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay.Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancer.Enrichment and Detection of Circulating Tumor Cells and Other Rare Cell Populations by Microfluidic Filtration.
P2860
Q34611922-40AD0198-5926-4A26-A7B8-FF321E1BFE0CQ35626055-06B90109-886B-49CD-A5F7-533DEFB7C595Q35655761-D09FDA02-B8B9-4B5C-858A-B96D48636CA3Q35818839-48AF1214-571A-4963-A838-7722EC99DB02Q36242936-08AD8C8D-3A09-4790-9411-41F42BC5078DQ38765489-9A5AFB4E-DB36-4BF3-8C70-04E5D91075EAQ46130140-A780472B-2FB2-4B26-B2C9-8D4C036342B3
P2860
Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Optimisation of an immunohisto ...... s in circulating tumour cells.
@ast
Optimisation of an immunohisto ...... s in circulating tumour cells.
@en
type
label
Optimisation of an immunohisto ...... s in circulating tumour cells.
@ast
Optimisation of an immunohisto ...... s in circulating tumour cells.
@en
prefLabel
Optimisation of an immunohisto ...... s in circulating tumour cells.
@ast
Optimisation of an immunohisto ...... s in circulating tumour cells.
@en
P2093
P2860
P50
P356
P1433
P1476
Optimisation of an immunohisto ...... s in circulating tumour cells.
@en
P2093
David Moore
Jeffrey Cummings
Karen Morris
Matt Lancashire
Tony Elliot
P2860
P2888
P356
10.1186/1471-2407-14-226
P407
P577
2014-03-28T00:00:00Z
P5875
P6179
1035262560